Yes, insomnia is a recognized medical disorder. The DSM-5-TR, the standard diagnostic manual used in psychiatry and medicine, classifies it as “insomnia disorder,” defined by difficulty falling asleep, staying asleep, or waking too early despite having adequate opportunity to sleep. To qualify as a clinical diagnosis, the sleep difficulty must cause significant distress or impair daily functioning, occur at least three nights per week, and persist for three months or longer.
Why It’s Not Just “Bad Sleep”
The distinction matters because insomnia is fundamentally different from simply not getting enough sleep. Sleep deprivation happens when external circumstances cut into your sleep time: a demanding work schedule, a new baby, jet lag. If you gave a sleep-deprived person the chance to nap, they’d fall asleep easily. People with insomnia generally cannot. They lie in bed with the time and place to sleep and still can’t do it. That inability, even when exhausted, is the hallmark of the disorder.
This also means insomnia isn’t something you can fix by just “going to bed earlier.” The problem isn’t a lack of opportunity. It’s a disruption in the brain’s ability to transition into and maintain sleep.
What Happens in the Brain
The leading explanation for insomnia centers on a state called hyperarousal. Your brain has a built-in switch between wakefulness and sleep. During normal sleep, a cluster of neurons in the hypothalamus releases a calming chemical (GABA) that quiets the wake-promoting systems in your brainstem. In people with insomnia, that switch doesn’t flip cleanly.
The wake side stays too active. Brain imaging studies show that networks involved in emotion processing and alertness remain overactive relative to sleep-promoting networks. On a chemical level, the system that keeps you awake and alert (driven partly by norepinephrine, serotonin, and a wakefulness chemical called orexin) doesn’t fully stand down at night. The stress hormone cortisol also runs higher than normal, both day and night, reflecting an overactive stress response system.
Even the brain’s electrical activity tells the same story. EEG recordings of people with insomnia show more high-frequency brain waves during sleep, the kind associated with active thinking and alertness. Their brains look more “awake” even when they’re technically asleep, which explains why many people with insomnia feel like they barely slept even after a full night in bed.
A Shift in How Doctors Think About It
For decades, insomnia was treated as a symptom of something else. If you had depression and couldn’t sleep, the insomnia was considered “secondary” to the depression. Doctors assumed that treating the underlying condition would resolve the sleep problem. That approach has largely been abandoned.
Current diagnostic frameworks treat insomnia as its own condition, even when it coexists with depression, anxiety, chronic pain, or other health problems. The reasoning is straightforward: insomnia often persists after the co-occurring condition is treated, and leaving it unaddressed makes those other conditions harder to manage. The old primary-versus-secondary model has been replaced by a comorbid model, where insomnia and other conditions are treated simultaneously as independent problems.
Short-Term vs. Chronic Insomnia
Not every stretch of poor sleep qualifies as a disorder. Insomnia lasting less than three months is classified as short-term insomnia. It’s common during stressful life events, illness, or schedule changes, and it often resolves on its own. Chronic insomnia, the kind that meets the diagnostic threshold of three or more nights per week for three months or longer, is what clinicians treat as a disorder. About 10% of adults meet criteria for chronic insomnia at any given time.
The three-month cutoff isn’t arbitrary. Short-term sleep problems frequently self-correct, but once insomnia persists beyond that window, it tends to become self-reinforcing. People start developing anxiety about sleep itself, changing their habits in ways that make the problem worse (spending extra hours in bed, napping, using alcohol to fall asleep), and the hyperarousal state becomes entrenched.
Health Risks of Chronic Insomnia
Chronic insomnia carries measurable cardiovascular and metabolic risks. Large studies estimate that insomnia symptoms are associated with a 1.4-fold increase in the odds of high blood pressure and a 1.3 to 1.9-fold increase in the odds of type 2 diabetes. The risk of heart disease or stroke rises by roughly 1.3 to 1.7-fold.
These numbers climb sharply when insomnia is paired with objectively short sleep (less than six hours measured in a sleep lab). That combination is associated with a 5-fold increase in the odds of high blood pressure, a 2 to 3-fold increase in odds of type 2 diabetes, and a 2.5-fold increase in odds of cardiovascular disease. People with insomnia who still manage six or more hours of sleep tend to have lower risk, suggesting that total sleep time partially buffers the health consequences.
How Chronic Insomnia Is Treated
Cognitive behavioral therapy for insomnia (CBT-I) is the recommended first-line treatment for adults with chronic insomnia. It’s a structured program, typically lasting four to eight sessions, that addresses both the behaviors and thought patterns that keep insomnia going. Core techniques include sleep restriction (limiting time in bed to match actual sleep time, then gradually expanding it), stimulus control (retraining your brain to associate the bed with sleep rather than wakefulness), and cognitive restructuring to reduce anxiety about sleep.
CBT-I works as well as medication in the short term and better in the long term, because it addresses the underlying patterns rather than overriding them chemically. It can be delivered in person, through telehealth, or via app-based programs.
When medication is used, several classes are available. Some target wakefulness signals directly by blocking orexin receptors, helping the brain’s arousal system quiet down. Others work by enhancing the brain’s calming pathways. A third category mimics melatonin to promote sleep onset. Older sedatives like benzodiazepines are limited to short-term use because of their potential for dependence. Most prescription sleep medications are classified as controlled substances, with a few exceptions.
Insomnia vs. Normal Variation
Everyone has occasional bad nights. A few restless nights before a job interview or after a cross-country flight is a normal response to stress, not a disorder. The diagnostic line is drawn where sleep difficulty becomes frequent (three or more nights weekly), persistent (three months or more), and functionally impairing, meaning it affects your energy, mood, concentration, or ability to handle daily responsibilities. If your sleep problems are occasional and resolve when the trigger passes, that’s within the range of normal human experience.